Videos shared by the Government of Dubai Media Office highlight the logo displayed on information boards within Dubai's intelligent traffic systems, adding to the festive ambiance across the city.

Fred Grossman, DO, Coya’s Chief Medical Officer commented: "Our Treg focused pipeline continues its advancement with the goal of manufacturing an allogeneic (off the shelf) specific modality ...

Coya Therapeutics (COYA) provided a status update of its investigational regulatory T cell-derived exosome platform intended for the treatment of systemic and neurodegenerative diseases driven by ...

COYA stock opened at $6.68 on Thursday. The firm has a 50 day moving average of $6.33 and a 200-day moving average of $6.49. Coya Therapeutics has a 12-month low of $4.75 and a 12-month high of ...

Coya Therapeutics, Inc. (COYA) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings ...

HOUSTON - Coya Therapeutics, Inc. (NASDAQ: COYA), a clinical-stage biotech company with a market capitalization of approximately $110 million, announced progress on its platform for regulatory T ...

As part of the #RamadanInDubai campaign, Dubai is welcoming its visitors arriving through the city’s air and land ports during Ramadan with a special stamp featuring the #RamadanInDubai logo.

And what makes a new candidate drug called COYA 302, an investigational therapy for ALS, different? COYA 302 is a dual-mechanism investigational biologic combination therapy. To explore this ...

Shares of NASDAQ COYA opened at $6.56 on Thursday. The stock has a market capitalization of $109.72 million, a P/E ratio of -10.09 and a beta of 0.31. Coya Therapeutics has a one year low of $4.75 ...